Please login to the form below

Not currently logged in
Email:
Password:

Acadia

This page shows the latest Acadia news and features for those working in and with pharma, biotech and healthcare.

New leader at Medivir after setbacks

New leader at Medivir after setbacks

s board in May having previously had a 15-year stint as CEO of Acadia Pharma which came to end in 2015 after the company was forced to delay a filing

Latest news

  • Nuplazid backed by FDA panel as first-ever Parkinson's psychosis drug Nuplazid backed by FDA panel as first-ever Parkinson's psychosis drug

    Nuplazid backed by FDA panel as first-ever Parkinson's psychosis drug. Concludes Acadia Pharmaceuticals’ drug provides ‘ modest but meaningful’ benefits. ... Acadia Pharmaceuticals is celebrating an FDA panel verdict that could set its Nuplazid

  • Acadia shares increase as pimavanserin clears phase III trial Acadia shares increase as pimavanserin clears phase III trial

    Acadia shares increase as pimavanserin clears phase III trial. Demonstrated to reduce psychotic symptoms. ... They also suggest that Acadia may now move quickly ahead with trying to find a marketing partner for pimavanserin outside the US.

  • This month in 1901: Birth of Charles Brenton Huggins

    Born in Novia Scotia on September 22, 1901, Huggins was educated at the region's Acadia University, before spending time at Harvard Medical School and then the University of Michigan where

  • Clouded vision

    AGN· 203818 is an orally active, α-adrenoreceptor agonist that was discovered as part of a research programme between Allergan and ACADIA.

  • Striking a balance

    Xsira Pharmaceuticals, 7TM Pharma, Acadia Pharmaceuticals, Glenmark Pharmaceuticals, Esteve, Vernalis, OSI Pharmaceuticals, EPIX Pharmaceuticals, Bayer and Novasite Pharmaceuticals are all undertaking separate research projects to develop CB1

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Damien McDevitt moves from GSK to Acadia Pharmaceuticals Damien McDevitt moves from GSK to Acadia Pharmaceuticals

    US biopharmaceutical company Acadia Pharmaceuticals has appointed Damien McDevitt (pictured) as senior vice president of corporate development. ... Meanwhile, Acadia’s SVP, technology development and operations Jim Nash will retire in January.

  • Juniper Pharmaceuticals adds to board of directors Juniper Pharmaceuticals adds to board of directors

    Dr Gray has over 20 years of biotechnology and biopharmaceutical experience and is the owner and president of Gray Strategic Advisors as well as serving on the boards of Acadia Pharmaceuticals,

  • Srdjan Stankovic joins Acadia Pharmaceuticals Srdjan Stankovic joins Acadia Pharmaceuticals

    Srdjan Stankovic joins Acadia Pharmaceuticals. He moves to the San Diego biopharma from Alkermes. ... Acadia is at the forefront in developing groundbreaking medicines to treat debilitating symptoms associated with these diseases.

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics